SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Pink who wrote (12291)12/15/1999 11:11:00 PM
From: TRIIBoy  Read Replies (2) of 18998
 
VTIV is TRIIBoy's latest sacrificial offering to Mr. P&nk and his nation of p&nkos. This could be better than BELFA.

VTIV. Ventiv health.

In the time honored tradition of SONO, TRIH and AGX:

1)They are a spin-off from Snyder Communication on Sept 30

2)Pharmaceuticals companies outsource sales and marketing functions to VTIV. They have the salesmen and marketing people to help "co-promote" drugs. Much like the CROs do with research.

3)Just got a huge $350 to $450 million 6 year contract with BMY, involves over 700 salesmen on VTIV's sake.

4)In two years (2001), I'm looking for $0.80 to $1.00 in earnings and $400 to $500 million in revenue. Currently has a $200 million market cap.

5)Company also has no debt, $1 in cash, insiders are buying.

6)Management has top notch credentials, including education.

I think that next year as people discover this it doubles.

Look past current losses as the company is ramping up contracts, such as the BMY and European operations are restructured.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext